926
Views
0
CrossRef citations to date
0
Altmetric
Article

Is vitamin D status associated with non-communicable disease risk in children? A cohort study

, &

References

  • Harkness LS, Bonny AE. Calcium and vitamin D status in the adolescent: key roles for bone, body weight, glucose tolerance, and estrogen biosynthesis. J Pediatr Adolesc Gynecol. 2005;18:305–311.
  • van der Mei IA, Ponsonby AL, Engelsen O, et al. The high prevalence of vitamin D insufficiency across Australian populations is only partly explained by season and latitude. Environ Health Perspect. 2007;115:1132–1139.
  • Chacko SA, Song Y, Manson JE, et al. Serum 25-hydroxyvitamin D concentrations in relation to cardiometabolic risk factors and metabolic syndrome in postmenopausal women. Am J Clin Nutr. 2011;94:209–217.
  • Yin X, Yan L, Lu Y, et al. Correction of hypovitaminosis D does not improve the metabolic syndrome risk profile in a Chinese population: a randomized controlled trial for 1 year. Asia Pac J Clin Nutr. 2016;25:71–77.
  • Pavlovic D, Josipovic J, Pavlovic N. Vitamin D and hypertension. Period Biol. 2011;113:299–302.
  • Sacheck J, Goodman E, Chui K, et al. Vitamin D deficiency, adiposity, and cardiometabolic risk in urban schoolchildren. J Pediatr. 2011;159:945–950.
  • Holick MF. Diabetes and the vitamin d connection. Curr Diab Rep. 2008;8:393–398.
  • Bikle DD, Jiang Y. The protective role of vitamin d signaling in non-melanoma skin cancer. Cancers (Basel). 2013;5:1426–1438.
  • Allali F, El Aichaoui S, Khazani H, et al. High prevalence of hypovitaminosis D in Morocco: relationship to lifestyle, physical performance, bone markers, and bone mineral density. Semin Arthritis Rheum. 2009;38:444–451.
  • Arunabh S, Pollack S, Yeh J, et al. Body fat content and 25-hydroxyvitamin D levels in healthy women. J Clin Endocrinol Metab. 2003;88:157–161.
  • Bassil D, Rahme M, Hoteit M, et al. Hypovitaminosis D in the Middle East and north Africa: prevalence, risk factors and impact on outcomes. Dermatoendocrinol. 2013;5:274–298.
  • Binkley N, Krueger D, Cowgill CS, et al. Assay variation confounds the diagnosis of hypovitaminosis D: a call for standardization. J Clin Endocrinol Metab. 2004;89:3152–3157.
  • Gannage-Yared MH, Chemali R, Yaacoub N, et al. Hypovitaminosis D in a sunny country: relation to lifestyle and bone markers. J Bone Miner Res. 2000;15:1856–1862.
  • Forman JP, Giovannucci E, Holmes MD, et al. Plasma 25-hydroxyvitamin D levels and risk of incident hypertension. Hypertension. 2007;49:1063–1069.
  • Rajakumar K, de las HJ, Chen TC, et al. Vitamin D status, adiposity, and lipids in black American and caucasian children. J Clin Endocrinol Metab. 2011;96:1560–1567.
  • Dong Y, Stallmann-Jorgensen IS, Pollock NK. A 16-week randomized clinical trial of 2000 international units daily vitamin D3 supplementation in black youth: 25-hydroxyvitamin D, adiposity, and arterial stiffness. J Clin Endocrinol Metab. 2010;95:4584–4591.
  • Ashraf A, Alvarez J, Saenz K, et al. Threshold for effects of vitamin D deficiency on glucose metabolism in obese female African-American adolescents. J Clin Endocrinol Metab. 2009;94:3200–3206.
  • Barlow SE, Bobra SR, Elliott MB, et al. Recognition of childhood overweight during health supervision visits: does BMI help pediatricians? Obesity. 2007;15:225–225.
  • Cole TJ, Bellizzi MC, Flegal KM, et al. Establishing a standard definition for child overweight and obesity worldwide: international survey. Br Med J. 2000;320:1240.
  • Flynn JT, Kaelber DC, Baker-Smith CM, et al. Clinical practice guideline for screening and management of high blood pressure in children and adolescents. Pediatrics. 2017;140:e20171904.
  • Juhola J, Magnussen CG, Viikari JS, et al. Tracking of serum lipid levels, blood pressure, and body mass index from childhood to adulthood: the cardiovascular risk in young Finns study. J Pediatr. 2011;159:584–590.
  • Lips P. Which circulating level of 25-hydroxyvitamin D is appropriate? J Steroid Biochem Mol Biol. 2004;89-90:611–614.
  • Lamberg-Allardt C. Vitamin D in children and adolescents. Scand J Clin Lab Invest Suppl. 2012;243:124–128.
  • Holick MF. Vitamin D deficiency. N Engl J Med. 2007;357:266–281.
  • Heaney RP. What is vitamin D insufficiency? And does it matter? Calcif Tissue Int. 2013;92:177–183.
  • Reis JP, von MD, Miller ER,III, et al. Vitamin D status and cardiometabolic risk factors in the United States adolescent population. Pediatrics. 2009;124:e371–e379.
  • Kelishadi R, Farajzadegan Z, Bahreynian M. Association between vitamin D status and lipid profile in children and adolescents: a systematic review and meta-analysis. Int J Food Sci Nutr. 2014;65:404–410.
  • Williams DM, Fraser A, Sayers A, et al. Associations of childhood 25-hydroxyvitamin D2 and D3 and cardiovascular risk factors in adolescence: prospective findings from the Avon longitudinal study of parents and children. Eur J Prev Cardiol. 2014;21:281–290.
  • Wortsman J, Matsuoka LY, Chen TC, et al. Decreased bioavailability of vitamin D in obesity–. Am J Clin Nutr. 2000;72:690–693.
  • Holick MF. Resurrection of vitamin D deficiency and rickets. J Clin Invest. 2006;116:2062–2072.
  • Gilbert-Diamond D, Baylin A, Mora-Plazas M, et al. Vitamin D deficiency and anthropometric indicators of adiposity in school-age children: a prospective study–. Am J Clin Nutr. 2010;92:1446–1451.
  • Dong Y, Pollock N, Stallmann-Jorgensen IS, et al. Low 25-hydroxyvitamin D levels in adolescents: race, season, adiposity, physical activity, and fitness. Pediatrics. 2010;125:1104–1111.
  • Blum M, Dolnikowski G, Seyoum E, et al. Vitamin D 3 in fat tissue. Endocrine. 2008;33(1):90–94.
  • Drincic AT, Armas LA, Van Diest EE, et al. Volumetric dilution, rather than sequestration best explains the low vitamin D status of obesity. Obesity. 2012;20:1444–1448.
  • Bouillon R, Bikle D. Vitamin D metabolism revised: fall of dogmas. J B M R. 2019;34:1985–1992.
  • Kao KT, Abidi N, Ranasinha S, et al. Low vitamin D is associated with hypertension in paediatric obesity. J Paediatr Child Health. 2015;51:1207–1213.
  • Li YC. Vitamin D regulation of the renin–angiotensin system. J Cell Biochem. 2003;88:327–331.
  • Olson ML, Maalouf NM, Oden JD, et al. Vitamin D deficiency in obese children and its relationship to glucose homeostasis. J Clin Endocrinol Metab. 2012;97:279–285.
  • Dolinsky DH, Armstrong S, Mangarelli C, et al. The association between vitamin D and cardiometabolic risk factors in children: a systematic review. Clin Pediatr. 2013;52:210–223.
  • Kumaratne M, Early G, Cisneros J. Vitamin D deficiency and association With body mass index and lipid levels in hispanic American adolescents. G B H. 2017;4:2333794X17744141.
  • Stokić E, Kupusinac A, Tomić-Naglić D, et al. Obesity and vitamin D deficiency: trends to promote a more proatherogenic cardiometabolic risk profile. Angiology. 2015;66:237–243.
  • Wang TJ, Pencina MJ, Booth SL, et al. Vitamin D deficiency and risk of cardiovascular disease. Circulation. 2008;117:503–511.
  • Nam GE, Kim DH, Cho KH, et al. 25-Hydroxyvitamin d insufficiency is associated with cardiometabolic risk in Korean adolescents: the 2008–2009 Korea National Health and nutrition examination survey (KNHANES). Public Health Nutr. 2014;17:186–194.